chevron_leftBack
Shanghai MicroPort Endovascular MedTech Co., Ltd.
688016
86.50CNY
-0.7%
11.87 USD
As of 24 April 2025, Shanghai MicroPort Endovascular MedTech Co., Ltd. has a market cap of $1.46B USD, ranking #6520 globally and #1568 in China. It ranks #613 in the Healthcare sector, and #65 in the Medical Devices industry.
Key Stats
Market Cap
$1.46BUSD
10.66B CNY
Enterprise Value
$1.17BUSD
8.56B CNY
Revenue (TTM)
$165.55MUSD
1.21B CNY
EBITDA (TTM)
$82.77MUSD
603.12M CNY
Net Income (TTM)
$68.9MUSD
502.1M CNY
EBITDA Margin
50%
Profit Margin
42%
PE Ratio
21.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Qing Zhu
open_in_new
Employees
908
Founded
2012
Website
endovastec.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.7% | -1.8% | -5.3% | -19% | -15% | -24% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688016
上海微创心脉医疗科技股份有限公司 Class A
ISIN: CNE100003MJ5
Shares Out.:
Shares Outstanding:
121.996M1
Shares Float:
70.642M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
86.50 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shanghai MicroPort Endovascular MedTech Co., Ltd.
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People’s Republic of China.
